IPO-Advanced Enzyme Technologies Ltd July 2016
Advanced Enzyme Technologies Ltd is coming up with a further Public Offer (IPO) of its shares between 20 July 2016 to 22 July 2016. Fresh Issue of shares aggregating upto Rs. 50 Crores and offer for sale of 40,34,470 Equity Shares
The price band of issue is Rs. 880 to Rs. 896.
The minimum application size and bid lot 16 Equity Shares and in multiples of 16 Equity Shares thereof.[wptabs mode=”horizontal”] [wptabtitle] Issue Details[/wptabtitle] [wptabcontent]
Advanced Enzyme Technologies Ltd IPO Payment Schedule for Retail Application
|IPO||Advanced Enzyme Technologies Ltd|
|Issue Open||20 July 2016|
|Issue Close||22 July 2016|
|Issue Size||405.03 to 411.49 Cr|
|Price Band||Rs. 880 to Rs. 896|
|Maximum Bid Amount||200000 (2 Lakh)|
|Bid Lot||16 Equity Shares & in multiple thereof|
|Cheque in Favour of (Retail Investor)|
|Face Value||Rs. 10 Per Equity Share|
|Listing||BSE & NSE|
About Advanced Enzyme Technologies Ltd Business:
Advanced Enzyme Technologies (AETL) was incorporated on 15 March 1989. Company started primarily as a pharmaceutical company and over the years diversified into different human nutrition, animal nutrition segment, etc. Company commenced the first fermentation facility in the year 1991 with production of around 7 enzymes and the first application research facility in the year 1996. The company presently operates in two key verticals namely Healthcare & Nutrition and Bio Processing.
The Company was promoted by Mr. Vasant Laxminarayan Rathi and Mr. Chandrakant Laxminarayan Rathi having a cumulative experience of over seven decades in the global enzyme industry. Under their leadership and guidance, AFTL is successful in creating a strong footing in the existing markets as well as expanding their presence in new and unexplored markets.
Advanced Enzyme Technologies (AETL) is the largest Indian Enzyme Company engaged in the Research & Development, Manufacturing and Marketing of more than 400+ proprietary Enzyme products developed from 60 indigenous enzymes operating in two primary business verticals namely Healthcare & Nutrition and Bio Processing some of the world’s largest and well-known organizations, including 49 of the Fortune Global 500 companies.
AETL Ranks among the top 15 global companies in terms of enzyme sales, and have the 2th highest market share domestically, next only to the world’s largest enzyme company Novozymes. It has 6 manufacturing units and 4 R&D facilities in India and abroad.
AFTl offer these products to more than 700 customers spanning across 50 countries worldwide. It supply these value-added eco-safe enzyme products to diverse end-user industries like Human Healthcare and Nutrition, Animal Nutrition, Food Processing, Cereal Extraction, Brewing, Grain Processing, Protein Processing, Oil and Fat Processing, Biomass Processing, Textile and Leather Processing Paper and Pulp Processing, Bio-fuels, Bio-Catalysis etc.
AFTL has a de-risked business model having diversified client base with their Top 10 customers accounting for 41.48% of the Total Revenues on consolidated basis for the fiscal year ended Mar 31, 2016. Some of their of their customers includes Sanofi India, Cipla, Ipca Laboratories, Alkem Laboratories, and Emcure Pharmaceuticals.
[/wptabcontent] [wptabtitle] Allotment & Listing Details[/wptabtitle] [wptabcontent]
Advanced Enzyme Technologies Ltd -ISIN, Script Code, Listing & Allotment Details in Below Table-
7, Omkar Corner, opp Cosmos Bank ,
Tilak Road, Sadashiv Peth,
Mobile: 77 1991 7444